Profiel
Garth Lees-Rolfe currently works at Ludwig Enterprises, Inc., as Independent Director from 2025.
Mr. Lees-Rolfe also formerly worked at F-star Therapeutics, Inc., as Vice President-Finance from 2021 to 2022 and Inhibikase Therapeutics, Inc., as Chief Financial & Accounting Officer from 2024 to 2025.
Mr. Lees-Rolfe received his undergraduate degree from Queensland University of Technology.
Actieve functies van Garth Lees-Rolfe
| Bedrijven | Functie | Begin |
|---|---|---|
| LUDWIG ENTERPRISES, INC. | Directeur/Bestuurslid | 23-06-2025 |
Eerdere bekende functies van Garth Lees-Rolfe
| Bedrijven | Functie | Einde |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Financieel Directeur/CFO | 11-04-2025 |
| F-STAR THERAPEUTICS, INC. | Corporate Officer/Principal | 01-11-2022 |
Opleiding van Garth Lees-Rolfe
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Queensland University of Technology
Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig Enterprises, Inc.
Ludwig Enterprises, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
F-star Therapeutics, Inc.
F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
















